# Neuromodulation and Language Acquisition (Project Stage Ia)

> **NCT00102284** · PHASE4 · TERMINATED · sponsor: **University Hospital Muenster** · enrollment: 100 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** levodopa
- **DRUG:** rivastigmine
- **DRUG:** pergolid
- **DRUG:** modafinil

## Key facts

- **NCT ID:** NCT00102284
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 100 (—)
- **Last updated:** 2010-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00102284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00102284, "Neuromodulation and Language Acquisition (Project Stage Ia)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00102284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*